deltatrials
Unknown PHASE1 INTERVENTIONAL 1-arm NCT03977090

Geptanolimab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer

Phase Ib Clinical Trial of Geptanolimab Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer

Sponsor: Genor Biopharma Co., Ltd.

Conditions Metastatic Colorectal Cancer
Interventions Fruquintinib Geptanolimab Injection
Updated 10 times since 2019 Last updated: Feb 8, 2021 Started: Apr 4, 2019 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03977090, this PHASE1 trial focuses on Metastatic Colorectal Cancer and remains ongoing. Sponsored by Genor Biopharma Co., Ltd., it has been updated 10 times since 2019, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jul 2019 – ~Dec 2019 · 5 months · monthly snapshotRecruiting~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshotRecruiting~Jan 2020 – ~Jun 2020 · 5 months · monthly snapshotRecruiting~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshotRecruiting~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshotRecruiting~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshotRecruiting~Mar 2021 – ~Mar 2023 · 24 months · monthly snapshotRecruiting~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1

    Status: Unknown Status → Unknown

  3. Mar 2023 — Jul 2024 [monthly]

    Unknown Status PHASE1

    Status: Recruiting → Unknown Status

  4. Mar 2021 — Mar 2023 [monthly]

    Recruiting PHASE1

  5. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE1

▶ Show 5 earlier versions

  1. Jul 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  2. Jun 2020 — Jul 2020 [monthly]

    Recruiting PHASE1

  3. Jan 2020 — Jun 2020 [monthly]

    Recruiting PHASE1

  4. Dec 2019 — Jan 2020 [monthly]

    Recruiting PHASE1

  5. Jul 2019 — Dec 2019 [monthly]

    Recruiting PHASE1

    First recorded

Apr 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Genor Biopharma Co., Ltd.
  • Hutchison Medipharma Limited
Data source: Genor Biopharma Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations